medline.ch Onkologie

	Drug Costs in Federally Sponsored Cancer Clinical Trials: A Systematic Review. JAMA Netw Open Xiao H, LeBlanc ML, Bertagnolli MM, Threlkel SA, Chansky M, Hershman DL, Unger JM. PMID: 42518232 [PubMed - as supplied by publisher]
	The effectiveness of Incentives on Cancer Screening Among Indigenous Populations: Systematic Review. Cancer Epidemiol Biomarkers Prev Khalaj N, Panahi I, McLaren EJ, Jahan S, Leitch J, Garvey G. PMID: 42518200 [PubMed - as supplied by publisher]
	Comparative Evaluation of AI Chatbots for Testicular Cancer Education: Validity, Information Quality, and Readability. Ann Surg Oncol Zhao J, Sun S, Zhao A, Liang R, Peng L, Peng X, Li R. PMID: 42518148 [PubMed - as supplied by publisher]
	Locally Recurrent Rectal Cancer in the Molecular Era: A Scoping Review of Biomarkers of Oncologic Outcome following Salvage Surgery. Ann Surg Oncol Vu JK, Younan E, Karunaratne S, Sutherland S, Sutton PA, You YN, Peacock O, Steffens D, Solomon MJ, Brown KGM. PMID: 42518147 [PubMed - as supplied by publisher]
	Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer. Drugs Lei L, Canning M, Sakach E, Lateef A, Kamga L, Abid M, Kalinsky K, Gandhi S. PMID: 42518131 [PubMed - as supplied by publisher]
	Perceptions of cognitive functioning among 10-year breast cancer survivors: a qualitative study. J Cancer Surviv Lopes C, Araújo N, Pereira S, Lunet N. PMID: 42518107 [PubMed - as supplied by publisher]
	Efficacy of walking or exercise for improving perceived cognitive function in adults during and after cancer therapy: a systematic review and network analysis. J Cancer Surviv Li L, Hui Z, Zhang Y, Wang X, Fan T. PMID: 42518106 [PubMed - as supplied by publisher]
	Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer. Curr Urol Rep Cosenza A, Quarta L, Galdieri A, Brancaccio M, Occhi A, Porzi ME, Zaurito P, Viti A, Santangelo A, Scilipoti P, Scuderi S, Barletta F, Stabile A, Montorsi F, Briganti A, Gandaglia G. PMID: 42518100 [PubMed - as supplied by publisher]
	Neoadjuvant chemotherapy and surgery-based treatment with selective adjuvant chemotherapy for cT2N0 esophageal squamous cell carcinoma: a multicenter retrospective study. Esophagus Takeoka T, Miyata H, Tanaka K, Nakai S, Sugase T, Yamamoto M, Kanemura T, Sugimura K, Makino T, Takeno A, Shiraishi O, Motoori M, Yamasaki M, Hirao M, Fujitani K, Yasuda T, Yano M, Doki Y. PMID: 42518071 [PubMed - as supplied by publisher]
	Second primary cancers among females with a first primary cervical, uterine and ovarian cancer: a population-based study in North Portugal. Cancer Causes Control Gonçalves E, Fontes F, Rodrigues JR, Calisto R, Bento MJ, Lunet N, Morais S. PMID: 42518015 [PubMed - as supplied by publisher]
	Cancer-associated fibroblasts: The silent conductors of tumor evolution and therapy refractoriness. Mol Biol Rep Kolahchi F, Karimi F, Kheshtchin N. PMID: 42517964 [PubMed - as supplied by publisher]
	Dosimetric and spatial impact of high-resolution SPACE MRI on target delineation for glomus tumor radiosurgery: a retrospective cohort study. J Neurooncol Thimmarayappa A, Beniwal M, Saini J, Sadashiva N, Konar SK, Srinivas D, Arimappamagan A, Vazhayil V, Andiperumal Raj P, Shashidhar A, Deora H, Birua GJS, Govindarajan N, Balakrishnan J, Natesan P. PMID: 42517943 [PubMed - as supplied by publisher]
	Impact of central review and MRI image quality on prostate cancer diagnosis and biopsy decision-making in referred patients. Abdom Radiol (NY) Zheng Z, Liu Y, Wu S, Chen Y, Jin P, Shi L, Zhang G, Sun H, Wang X, Xu L. PMID: 42517901 [PubMed - as supplied by publisher]
	Closing the completion colonoscopy gap: key takeaways from the American Society for Gastrointestinal Endoscopy's 2025 National Colorectal Cancer Screening Summit. Gastrointest Endosc Hosseini-Carroll P, Dominitz JA, Jacobson BC, May FP, Issaka RB, Schmitt CM, Adams TL, Boston IJ, Bucobo JC, Day L, Khaykis IB, Marino MJ, Rex DK, Sun E, Wynter JA, Christie JA. PMID: 42517844 [PubMed - as supplied by publisher]
	Use of whole-body MRI to evaluate residual tumour burden after initial systemic therapy in polymetastatic hormone-sensitive prostate cancer. Br J Radiol Thompson C, Withey SJ, Tunariu N, Parker C, Tree A, Reid A, Pathmanathan A, Murray J. PMID: 42517815 [PubMed - as supplied by publisher]
	Cardiovascular risk factors, primary tumor origin, and carcinoid heart disease in patients with neuroendocrine tumors: a retrospective cross-sectional study. Pol Arch Intern Med Rudzinski PN, Gonet M, Demkow J, Henzel J, Konsek-Komorowska SJ, P. PMID: 42517791 [PubMed - as supplied by publisher]
	In situ self-assembly of PROTACs for precision cancer therapy. Chem Commun (Camb) Liang P, Ren Y, Bian Y, Su D. PMID: 42517780 [PubMed - as supplied by publisher]
	Erratum for: (61)Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of (61)Cu-labeled PET Radiotracers. Radiology Ulaner GA, Bassett JC, Reddy R, Thomsen B, Reynolds D, Jerjian KJ, Wolfe R, Benjamin DJ, Fani M, O'Donoghue J, Baier M, Schubert N, Pais B, De Rose F, Jaafar L. PMID: 42517773 [PubMed - as supplied by publisher]
	Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial. Radiology McClure TD, Wang S, Ballman KV, Diven M, Osborne JR, O'Dwyer E, Piscopo J, Khani F, Marciscano A, Al Hussein Al Awamlh B, Barbieri C, Nagar H. PMID: 42517770 [PubMed - as supplied by publisher]
	Radiograph-based Deep Learning Algorithm for Assisting Bone Tumor Risk Assessment: A Multicenter Study. Radiology Song C, Xu J, Jiang T, Wang X, Tang J, Wang Z, Chen Y, Wang L, Li X, Zou J, Hou L, Guan S, Cui J, Xu W, Nie P, Wang T, Zhao X, Huang C, Chen S, Duan F, Wan G, Wang H, Hao D. PMID: 42517768 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1959081

Seite 1 von 97955

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung